The effectiveness of catheter-based renal denervation therapy (RDN) for hypertension depends on the magnitude of systolic blood pressure (SBP) reduction, age, and risk factors for cardiovascular disease.
The effectiveness of catheter-based renal denervation therapy (RDN) for hypertension depends on the magnitude of systolic blood pressure (SBP) reduction, age, and risk factors for cardiovascular disease.